- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Avalere Survey Finds Cancer Hospitals Are Participating in Exchange Plans
Avalere, partnering with the National Comprehensive Care Network, surveyed 20 cancer centers and found that 75% of respondents were covered by at least "some" of the exchange plans in their state.
Most specialized cancer hospitals say they participate in the narrow provider networks of some exchange health plans, but health insurers have not been shy keeping some cancer hospitals out, according to a new survey from consulting firm Avalere Health.
The Avalere analysis follows an Associated Press report last year which found that many of America's most prestigious cancer hospitals were getting excluded from health plans sold on the Affordable Care Act exchanges in 2014. Household names like MD Anderson Cancer Center in Houston and Memorial Sloan Kettering Cancer Center in New York City had in-network agreements with a handful of exchange plans, the AP reported.
But other plans excluded them, and they were considered out-of-network and thus more costly for patients. Insurers said they weren't able to negotiate acceptable rates with cancer hospitals and other specialty providers, such as children's hospitals, in some markets.
Read the complete article at Modern Healthcare: http://bit.ly/1IL8sI9
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
